Arterial and interstitial remodelling processes in non-specific interstitial pneumonia: Systemic sclerosis versus idiopathic

Histopathology

Volumn 53, Issue 2, 2008, Pages 195-204

  De Carvalho, E F ^a   Parra, E R ^a   De Souza, R ^a   A'B Saber, A M ^a   De Carvalho Machado, J ^a   Capelozzi, V L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Collagen fibres; Elastic fibres; Matrix remodelling; Non specific interstitial pneumonia; Systemic sclerosis

Indexed keywords

CARBON MONOXIDE;

ADULT; ARTERY OCCLUSION; ARTERY RECONSTRUCTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ELASTIC FIBER; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG FUNCTION TEST; LUNG VOLUME; MALE; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY ARTERY; RESIDUAL VOLUME; SURVIVAL; SYSTEMIC SCLEROSIS;

ARTERIES; FEMALE; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PULMONARY FIBROSIS; SCLERODERMA, SYSTEMIC;

EID: 47749154461     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.03072.x     Document Type: Article

References (40)

1. Jimenez SA, Derk CT. Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann. Intern. Med. 2004 140 37 50.
2. Basu D, Reveille JD. Anti-scl-70. Autoimmunity 2005 38 65 72.
3. Steen VD, Conte C, Owens GR, Medsger TA Jr. Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum. 1997 40 1984 1991.
4. Wells AU, Hansell DM, Rubens MB, Cailes J, Black CM, du Bois RM. Functional impairment in lone cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a comparison. Am. J. Respir. Crit. Care Med. 1997 156 1657 1664.
5. Wells AU, Cullinan P, Hansell DM et al. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis. Am. J. Respir. Crit. Care Med. 1994 149 1583 1590.
6. Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am. J. Surg. Pathol. 1994 18 136 147.
7. American Thoracic Society/European Respiratory Society (2001) International Multidisciplinary Consensus Classification of the Interstitial Pneumonia. Am. J. Respir. Crit. Care Med. 2002 65 277 304.
8. Ito I, Nagai S, Kitaichi M et al. Pulmonary manifestations of primary Sjögren's syndrome: a clinical, radiologic, and pathologic study. Am. J. Respir. Crit. Care Med. 2005 171 632 638.
9. Douglas WW, Tazelaar HD, Hartman TE et al. Polymyositis-dermatomyositis associated interstitial lung disease. Am. J. Respir. Crit. Care Med. 2001 164 1182 1185.
10. Kim DS, Yoo B, Lee JS et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc. Diffuse Lung Dis. 2002 19 121 127.
11. Bouros D, Wells AU, Nicholson AG et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am. J. Respir. Crit. Care Med. 2002 165 1581 1586.
12. Steen VD. The lung in systemic sclerosis. J. Clin. Rheumatol. 2005 11 40 46.
13. Fietta AM, Bardoni AM, Salvini R et al. Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. Arthritis Res Ther. 2006 8 R160.
14. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980 23 581 590.
15. American Thoracic Society. Standardization of spirometry, 1994 update. Am. J. Respir. Crit. Care Med. 1995 152 1107 1136.
16. Quanjer PhH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault J-C. Lung volumes and forced ventilatory flows. Report working party, Standardization of lung function tests, European Community for steel and coal. Official Statement of the European respiratory Society. Eur. Respir. J. 1993 16 5 40.
17. Parra ER, Kairalla RA, de Carvalho CR, Capelozzi VL. Abnormal deposition of collagen-elastic vascular fibres and prognostic significance in idiopathic interstitial pneumonias. Thorax 2007 62 428 437.
18. Montes GS. Structural biology of the fibers of the collagenous and elastic systems. Cell Biol. Int. 1996 20 15 27.
19. Weibel ER. Principles and methods for the morphometric study of the lung and other organs. Lab. Invest. 1963 12 131 155.
20. Fujita J, Yamadori I, Bandoh S et al. Clinical features of non-specific interstitial pneumonia. Intern. Med. 2000 93 407 411.
21. White B, Moore WC, Wigley FM, Xiao HQ, Wise RA. Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Arch. Intern. Med. 2000 132 947 954.
22. Latsi PI, Wells AU. Evaluation and management of alveolitis and interstitial lung disease in scleroderma. Curr. Opin. Rheumatol. 2003 15 748 755.
23. Tashkin DP, Elashoff R, Clements PJ et al. Cyclophosphamide versus placebo in scleroderma lung disease. N. Engl. J. Med. 2006 354 2655 2666.
24. Felicio CHC, Parra ER, Capelozzi VL. Idiopathic and collagen vascular disease nonspecific interstitial pneumonia: clinical significance of remodeling process. Lung 2007 185 39 46.
25. Rozin GF, Gomes MM, Parra ER, Kairalla RA, de Carvalho CRR, Capelozzi VL. Collagen and elastic system in the remodelling process of major types of idiopathic interstitial pneumonias (IIP). Histopathology 2005 46 413 421.
26. Ranzani OT, Parra ER, Fernezlian SM, Capelozzi VL. Intraluminal plugs in idiopathic and secondary organizing pneumonia: repair or remodelling? Histopathology 2007 51 622 630.
27. Starcher BC. Lung elastin and matrix. Chest 2000 117 229 234.
28. Fukuda Y, Basset F, Soler P, Ferrans VJ, Masugi Y, Crystal RG. Intraluminal fibrosis and elastic fiber degradation lead to lung remodeling in pulmonary Langerhans cell granulomatosis (histiocytosis X). Am. J. Pathol. 1990 137 415 424.
29. Fukuda Y, Ferrans VJ. Pulmonary elastic fiber degradation in paraquat toxicity. An electron microscopic immunohistochemical study. J. Submicrosc. Cytol. Pathol. 1988 20 15 23.
30. Mariani TJ, Crouch E, Roby JD, Starcher B, Pierce RA. Increased elastin production in experimental granulomatous lung disease. Am. J. Pathol. 1995 147 988 1000.
31. Raghow R, Lurie S, Seyer JM, Kang AH. Profiles of steady state levels of messenger RNAs coding for type I procollagen, elastin, and fibronectin in hamster lungs undergoing bleomycin-induced interstitial pulmonary fibrosis. J. Clin. Invest. 1985 76 1733 1739.
32. Pierce RA, Albertine KH, Starcher BC, Bohnsack JF, Carlton DP, Bland RD. Chronic lung injury in preterm lambs: disordered pulmonary elastin deposition. Am. J. Physiol. 1997 272 L452 L460.
33. Leick-Maldonado EA, Lemos M, Tibério IF et al. Differential distribution of elastic system fibers in control and bronchoconstricted intraparenchymatous airways in the guinea-pig lung. J. Submicrosc. Cytol. Pathol. 1997 29 427 434.
34. Konig G, Luderschmidt C, Hammer C, Adelmann-Grill BC, Braun-Falco O, Fruhmann G. Lung involvement in scleroderma. Chest 1984 85 318 324.
35. Sibille Y, Martinot JB, Polomski LL et al. Phagocyte enzymes in bronchoalveolar lavage from patients with pulmonary sarcoidosis and collagen vascular disorders. Eur. Respir. J. 1990 3 249 256.
36. Nagao T, Nagai S, Kitaichi M et al. Usual interstitial pneumonia: idiopathic pulmonary fibrosis versus collagen vascular diseases. Respiration 2001 68 151 159.
37. King TE Jr., Schwarz MI, Brown K et al. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am. J. Respir. Crit. Care Med. 2001 164 1025 1032.
38. Daniil ZD, Gilchrist FC, Nicholson AG et al. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am. J. Respir. Crit. Care Med. 1999 160 899 905.
39. Saldiva PHN, Capelozzi VD, de Carvalho CRR, Kairalla RA, Auler JOC Jr. Histochemical evaluation of lung collagen content in acute and chronic interstitial diseases. Chest 1989 95 953 957.
40. Travis WD, Matsui K, Moss J, Ferrans VJ. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am. J. Surg. Pathol. 2000 24 19 33.